It has been shown that mutations in the RAS family genes (NRAS, KRAS, HRAS) are most commonly associated with follicular thyroid carcinoma (FTC), but they are also present in three other types, including anaplastic thyroid cancer (ATC). This evidence concerns the gene KRAS and thyroid gland undifferentiated (anaplastic) carcinoma.